Navigation Links
Sagent Pharmaceuticals Launches Ceftriaxone, USP, and Cefuroxime for Injection, USP
Date:7/16/2008

SCHAUMBURG, Ill., July 16 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced that it has launched both ceftriaxone for injection, USP, and cefuroxime for injection, USP, two broad spectrum antibiotics for parenteral administration used to treat bacterial infections. Sagent's ceftriaxone for injection will be available to the U.S. market in 250 mg and 500 mg single dose vials, as well as 1g and 2g single dose vials; cefuroxime for injection will be available in 750 mg and 1.5g single dose vials and in 7.5g pharmacy bulk package vials. According to IMS data, combined 2007 sales for the two antibiotics were $156 million.

"We are excited to introduce these two broad-spectrum antibiotics, incorporating important features unique to Sagent, including enhanced labeling designed to enable rapid and accurate product identification," said Jeffrey M. Yordon, Sagent's chief executive officer, founder, and chairman of the board. "Importantly, this marks our fifth and sixth product launches in the past eight months, in line with our objective of rapidly introducing safe, high- quality products from our pipeline of over 200 products. Sagent is committed to bringing injectables excellence to healthcare providers and patients."

About Ceftriaxone

Ceftriaxone for injection, USP, is a broad spectrum cephalosporin antibiotic used to treat a variety of infections and is the generic equivalent of Roche's Rocephin(R) (ceftriaxone for injection). Ceftriaxone for injection, USP, is indicated for infections of the lower respiratory tract, urinary tract, skin and skin-structure, intra-abdomen, and bones and joints, as well as acute otitis media, uncomplicated gonorrhea, pelvic inflammatory disease, bacterial septicemia and meningitis. Ceftriaxone may also reduce the incidence of postoperative infections is used as a surgical prophylaxis preoperatively.

The most common adverse effects may include nau
'/>"/>

SOURCE Sagent Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
2. Sagent Pharmaceuticals, Inc. to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
3. Sagent Pharmaceuticals Launches Cefazolin for Injection, USP
4. Sagent Pharmaceuticals Provides US$20,000 in Aid to Earthquake-Devastated Areas in Central China
5. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
11. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014  Decision Resources ... and medical directors in the United ... of biosimilar market penetration will be the level ... (MCOs) and the expected lower cost to patients. ... biosimilars that meet their pricing expectations in order ...
(Date:7/30/2014)... 2014  Replikins Ltd. today released new data on ... Before the current outbreaks, the mean Ebola Reston gene ... between 1995 and 2002 was 1.1; the mean Replikin ... sixteen-fold in 2013, thus predicting the current outbreaks in ... been shown to be able to predict outbreaks (1). ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Sales Horizons, ... launch of blended sales training programs for companies engaged ... training programs used by thousands of salespeople over 25 ... sales training program can be customized to address the ... The blended sales training program consists of ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 July 30, ... @APDN), a biotechnology firm that provides DNA-based authentication and ... Hogan, Ph.D. Vice President of Life Sciences, a newly ... , Dr. Hogan will lead APDN’s drive to ... relationships with biotech and healthcare customers, provide guidance to ...
Breaking Biology Technology:Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 2Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 3Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 2Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 3
... Ryan MILWAUKEE - Watts Wacker, hippie extraordinaire and rock-star ... birthday bash last week. I was floored by his ... notes. Here's what Watts offered, along with some R-squared ... 200 Christians. When Paulone of JC's disciplesfinally laid down, ...
... August, those seven days in which we attempt to pack all ... For me, this week also signals the calm before the storm. ... 2004. (Its a great lineup, so if you haven't grabbed your ... should be polishing my opening comments and prepping my introductions, but ...
... are millions of very expensive, well-designed websites all over ... offer with great graphic illustrations, supportive explanations about their ... in a very large majority of cases, what is ... people behind the site: the owners, the management the ...
Cached Biology Technology:Watts Up 2Wrapping up the Summer 2Wrapping up the Summer 3Wrapping up the Summer 4Whats Hush-Hush Marketing? 2Whats Hush-Hush Marketing? 3
(Date:7/31/2014)... as the Rim Fire was in full fury, raging ... it entered the backcountry of Yosemite National Park in ... the park, the battle began to turn, enacting a ... can combine to fuel large, severe fires. , "When ... lands where fire had been used as a management ...
(Date:7/31/2014)... with Hibiscus flowers- they are an iconic symbol ... planted in the landscape. Some, like Hawaii,s State ... , Only a relatively few botanists and Hawaiian ... beautiful and intriguing related group of plants known ... , Brother of Hibiscus species are in fact ...
(Date:7/31/2014)... White, brown and beige adipocytes, or fat cells, are ... functions and each plays its own role in metabolism. ... far the most prevalent. Its primary function is energy ... energy to generate heat but are only found in ... adipocytes, which represent a special type of brown adipocytes, ...
Breaking Biology News(10 mins):The Rim Fire 1 year later: A natural experiment in fire ecology and management 2The Rim Fire 1 year later: A natural experiment in fire ecology and management 3The Rim Fire 1 year later: A natural experiment in fire ecology and management 4The Rim Fire 1 year later: A natural experiment in fire ecology and management 5Brother of Hibiscus is found alive and well on Maui 2Hope for the overweight 2
... Edition: , , New hope for tapping vast domestic reserves ... to use in the U. S. , Toward a fast, ... proteins identified in the quest for male contraceptive, Toward more ... Resources: , Press releases, chat room sessions, and more ...
... The National Institutes of Health announced today that it ... NIH Director,s Pioneer and New Innovator Awards to 47 ... of their careers. The grants, estimated to be up ... pursue exceptionally innovative approaches that could transform biomedical and ...
... are thought to be involved in colon cancer but the ... have discovered that a molecule produced by a common gut ... The research, published in the October issue of the ... gut bacteria can cause colon cancer. There are more ...
Cached Biology News:ACS PressPac -- Sept. 17, 2008 2ACS PressPac -- Sept. 17, 2008 3ACS PressPac -- Sept. 17, 2008 4ACS PressPac -- Sept. 17, 2008 5ACS PressPac -- Sept. 17, 2008 6ACS PressPac -- Sept. 17, 2008 7ACS PressPac -- Sept. 17, 2008 8NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards 2NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards 3NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards 4NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards 5NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards 6NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards 7NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards 8NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards 9Cancer-causing gut bacteria exposed 2
Mouse polyclonal antibody to TNPO2 - transportin 2 (importin 3, karyopherin beta 2b)...
...
Mouse monoclonal antibody to ALAS2 - aminolevulinate, delta-, synthase 2 (sideroblastic/hypochromic anemia)...
... of an N-terminal FLAG® fusion and a ... from bicistronic mRNA. Two genes can ... transcription of a single message from the ... protein-protein interaction studies, multi-subunit proteins, and cloning ...
Biology Products: